A company seeking to achieve practical commercial application of CRISPR-Cas3 technology, a genome editing technology invented in Japan
Development of novel therapies forgenetic diseases and genetically modified cells using CRISPR-Cas3 technology
Application of this technology platform not only in medical care but also other industries
Company name
C4U CORPORATION
Type of business
Medical(medical devices, drug discovery)
Representatives
Akimitsu Hirai
Establishing a company
March 2018
Investment announcement date
May 2023
Capitalist
Jun Hayashi
HP
https://www.crispr4u.jp/Phasing
Middle to Growth
